Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| GLOBUS MEDICAL INCGMED · Entity 3496 | Chief Accounting Officer | February 01, 2019 | February 11, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
GLOBUS MEDICAL INC
Report date February 01, 2019 · Filed February 11, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)SEC Table II · derivative / convertible security · Conversion / exercise price $43.87 · Expires 2029-02-01 | Direct | 7,500 |
Reported balance
After 2019-02-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-02-01 · Grant · Acquired 7,500 · Balance 7,500 F1: These options were granted on February 1, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. |
Filing footnotes · ownership attribution and instrument terms
F1: These options were granted on February 1, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 01, 2019 Filed Feb 11, 2019 21:51 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $43.87 | $0.00 |
DisclosureSEC source: 0001209191-19-008996 · doc4.xml · derivative · entry 1 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Class A Common Stock · 7,500 shares Expires 2029-02-01 F1 · derivative.exercise_date: These options were granted on February 1, 2019, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2020, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| September 26, 2018 Filed Oct 30, 2018 20:05 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 3,000 | $0.00 Strike: $12.59 | $0.00 |
DisclosureSEC source: 0001209191-18-056511 · doc4.xml · derivative · entry 3 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,000 shares Expires 2023-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on January 30, 2013, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2014, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| September 26, 2018 Filed Oct 30, 2018 20:05 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,000 | $56.00 | $168,000.00 |
DisclosureSEC source: 0001209191-18-056511 · doc4.xml · nonDerivative · entry 2 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person. Read SEC document |
| September 26, 2018 Filed Oct 30, 2018 20:05 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 3,000 | $12.59 | $37,770.00 |
DisclosureSEC source: 0001209191-18-056511 · doc4.xml · nonDerivative · entry 1 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 21:00 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 20,771 | $55.81 | $1,159,221.20 |
DisclosureSEC source: 0001209191-18-035208 · doc4.xml · nonDerivative · entry 1 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $55.75 to $55.945, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| January 22, 2018 Filed Jan 24, 2018 21:17 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $43.77 | $0.00 |
DisclosureSEC source: 0001209191-18-005093 · doc4.xml · derivative · entry 1 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Class A Common Stock · 7,500 shares Expires 2028-01-22 F1 · derivative.exercise_date: These options were granted on January 22, 2018, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2019, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionStock Option (Right to Buy Class A Common Stock) · Derivative | 3,076 | $0.00 Strike: $4.88 | $0.00 |
DisclosureSEC source: 0001209191-17-066110 · doc4.xml · derivative · entry 3 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Class A Common Stock · 3,076 shares Expires 2019-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on August 6, 2009, and vested over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2010, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | SaleClass A Common Stock | 3,076 | $39.30 | $120,892.64 |
DisclosureSEC source: 0001209191-17-066110 · doc4.xml · nonDerivative · entry 2 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,771 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.30 to $39.31, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. Read SEC document |
| December 15, 2017 Filed Dec 18, 2017 21:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | Exercise / conversionClass A Common Stock | 3,076 | $4.88 | $15,010.88 |
DisclosureSEC source: 0001209191-17-066110 · doc4.xml · nonDerivative · entry 1 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,847 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:07 UTC | GLOBUS MEDICAL INC GMED · Entity 3496 | GrantStock Option (Right to Buy Class A Common Stock) · Derivative | 7,500 | $0.00 Strike: $26.27 | $0.00 |
DisclosureSEC source: 0001209191-17-006657 · doc4.xml · derivative · entry 1 Payne Steven · CIK 0001578733 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Class A Common Stock · 7,500 shares Expires 2027-01-30 F1 · derivative.exercise_date: These options were granted on January 30, 2017, and vest over a four-year period with one-fourth (1/4) of the options granted vesting on January 1, 2018, the first anniversary of the vesting commencement date, and the balance of the options granted vesting ratably on a monthly basis over the following 36 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.